Principal Investigator
Scott Elman
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20251397
Clinical Trial Summary
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Lichen Planopilaris
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other